The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Natural products to drugs: daptomycin and related lipopeptide antibiotics
Abstract
Daptomycin (Cubicin) is a lipopeptide antibiotic approved in the USA in 2003 for the treatment of skin and skin structure infections caused by Gram-positive pathogens. It is a member of the 10-membered cyclic lipopeptide family of antibiotics that includes A54145, calcium-dependent antibiotic (CDA), amphomycin, friulimicin, laspartomycin, and others. This review highlights research on this class of antibiotics from 1953 to 2005, focusing on more recent studies with particular emphasis on the interplay between structural features and antibacterial activities; chemical modifications to improve activity; the genetic organization and biosynthesis of lipopeptides; and the genetic engineering of the daptomycin biosynthetic pathway to produce novel derivatives for further chemical modification to develop candidates for clinical evaluation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)
Bentley, S. D., Chater, K. F., Cerdeño-Tárraga, A.-M., Challis, G. L., Thomson, N. R., James, K. D., Harris, D. E., Quail, M. A., Kieser, H., Harper, D., et al. (2002) · Nature · doi:10.1038/417141a · Cited by 3,233
Gillet, Y., Issartel, B., Vanhems, P., Fournet, J.-C., Lina, G., Bes, M., Vandenesch, F., Piémont, Y., Brousse, N., Floret, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07877-7 · Cited by 1,514
The specificity-conferring code of adenylation domains in nonribosomal peptide synthetases
Stachelhaus, T., Mootz, H. D., & Marahiel, M. A. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80082-9 · Cited by 1,237
Shaw, K. J., Rather, P. N., Hare, R. S., & Miller, G. H. (1993) · Microbiological Reviews · doi:10.1128/mmbr.57.1.138-163.1993 · Cited by 1,196
Modular Peptide Synthetases Involved in Nonribosomal Peptide Synthesis
Marahiel, M. A., Stachelhaus, T., & Mootz, H. D. (1997) · Chemical Reviews · doi:10.1021/cr960029e · Cited by 1,126
Miller, L. G., Perdreau-Remington, F., Rieg, G., Mehdi, S., Perlroth, J., Bayer, A. S., Tang, A. W., Phung, T. O., & Spellberg, B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042683 · Cited by 1,053
Tillett, D., Dittmann, E., Erhard, M., von Döhren, H., Börner, T., & Neilan, B. A. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00021-1 · Cited by 995
Biosynthesis of Nonribosomal Peptides
Finking, R., & Marahiel, M. A. (2004) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123615 · Cited by 888
Bender, C. L., Alarcón-Chaidez, F., & Gross, D. C. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.2.266-292.1999 · Cited by 839
Regulation of secondary metabolism in streptomycetes
Bibb, M. J. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.02.016 · Cited by 821
Cited by
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Microbial biosurfactants production, applications and future potential
Banat, I. M., Franzetti, A., Gandolfi, I., Bestetti, G., Martinotti, M. G., Fracchia, L., Smyth, T. J., & Marchant, R. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-2589-0 · Cited by 1,474
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
New antibiotics from bacterial natural products
Clardy, J., Fischbach, M. A., & Walsh, C. T. (2006) · Nature Biotechnology · doi:10.1038/nbt1266 · Cited by 615
Small Bioactive Peptides for Biomaterials Design and Therapeutics
Hamley, I. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00522 · Cited by 461
Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains
Müller, A., Wenzel, M., Strahl, H., Grein, F., Saaki, T. N. V., Kohl, B., Siersma, T., Bandow, J. E., Sahl, H.-G., Schneider, T., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611173113 · Cited by 425
Traxler, M. F., Watrous, J. D., Alexandrov, T., Dorrestein, P. C., & Kolter, R. (2013) · mBio · doi:10.1128/mbio.00459-13 · Cited by 381
Antimicrobial peptides under clinical investigation
Koo, H. B., & Seo, J. (2019) · Peptide Science · doi:10.1002/pep2.24122 · Cited by 376
Opportunities for natural products in 21st century antibiotic discovery
Wright, G. D. (2017) · Natural Product Reports · doi:10.1039/c7np00019g · Cited by 343
Antimicrobial Peptides: An Update on Classifications and Databases
Bin Hafeez, A., Jiang, X., Bergen, P. J., & Zhu, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111691 · Cited by 341
Henkel, M., Müller, M. M., Kügler, J. H., Lovaglio, R. B., Contiero, J., Syldatk, C., & Hausmann, R. (2012) · Process Biochemistry · doi:10.1016/j.procbio.2012.04.018 · Cited by 320
The evolution of gene collectives: How natural selection drives chemical innovation
Fischbach, M. A., Walsh, C. T., & Clardy, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709132105 · Cited by 309
Gross, H., Stockwell, V. O., Henkels, M. D., Nowak-Thompson, B., Loper, J. E., & Gerwick, W. H. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.11.007 · Cited by 302
The action mechanism of daptomycin
Taylor, S. D., & Palmer, M. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.05.052 · Cited by 298
Combinatorial biosynthesis of novel antibiotics related to daptomycin
Nguyen, K. T., Ritz, D., Gu, J.-Q., Alexander, D., Chu, M., Miao, V., Brian, P., & Baltz, R. H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608589103 · Cited by 287
Self-citationDaptomycin: mechanisms of action and resistance, and biosynthetic engineering
Baltz, R. H. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.02.031 · Cited by 267
Self-citationRecent advances in engineering nonribosomal peptide assembly lines
Winn, M., Fyans, J. K., Zhuo, Y., & Micklefield, J. (2016) · Natural Product Reports · doi:10.1039/c5np00099h · Cited by 266
An oldie but a goodie – cell wall biosynthesis as antibiotic target pathway
Schneider, T., & Sahl, H.-G. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2009.10.005 · Cited by 261
Mehta, S., Singh, C., Plata, K. B., Chanda, P. K., Paul, A., Riosa, S., Rosato, R. R., & Rosato, A. E. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01525-12 · Cited by 142
Hmidet, N., Ben Ayed, H., Jacques, P., & Nasri, M. (2017) · BioMed Research International · doi:10.1155/2017/5893123 · Cited by 58
Three Bacterial DedA Subfamilies with Distinct Functions and Phylogenetic Distribution
Todor, H., Herrera, N., & Gross, C. A. (2023) · mBio · doi:10.1128/mbio.00028-23 · Cited by 29
Structure, Biosynthesis, and Bioactivity of Nostolysamides
(2026) · doi:10.1021/acs.biochem.6c00103 · Cited by 2
Metadata
- Authors
- Baltz, R. H., Miao, V., & Wrigley, S. K.
- Venue
- Natural Product Reports
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2005
- Volume
- 22
- Issue
- 6
- Pages
- 717
- ISSN
- 0265-0568 (ISSN-L)
- 1460-4752
- OpenAlex
- W2133399253
- Cited by
- 393
- References
- 118
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.